We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Value Investing Subreddit Page by Long-Access ...

WACC (Weighted Average Cost of Capital): 11.05%, coming from 11.5% cost of equity (about 11% I use for a no-moat stock, but I ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced the appointment of Adam Zaeske as its new Executive Vice ...

Investing.com — 和谐生物科学控股公司 (Harmony Biosciences Holdings, Inc.) (NASDAQ: HRMY)，一家市值20.2亿美元、毛利率高达78%的制药公司，宣布任命Adam Zaeske为新任执行副总裁兼首席商务官，自2025年3月31日起生效。Zaeske将接替因个人原因离职的Jeffrey Dierks。

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Ron Philip to the Company's Board of Directors. Ron Philip is the President and Chief Executive Officer of ...

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

PLYMOUTH MEETING, Pa., April 03, 2025--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Ron Philip to the Company's Board of Directors.

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Adam Zaeske as Executive Vice President and Chief Commercial Officer (CCO), effective March 31, 2025. The ...

KLP Kapitalforvaltning AS purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the 4th ...

Teacher Retirement System of Texas boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by ...

PLYMOUTH MEETING, Pa. - Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a pharmaceutical company focused on rare neurological diseases, announced the appointment of Ron Philip to its Board of ...

PLYMOUTH MEETING, Pa. - Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a pharmaceutical company focused on rare neurological diseases, announced the appointment of Ron Philip to its Board of ...